跳至主要内容
临床试验/NL-OMON20319
NL-OMON20319暂停不适用

Effectiveness of probiotics in the treatment of children with chronic abdominal pain and small intestinal bacterial overgrowth. A double blind placebo-controlled randomized study.

Jeroen Bosch hospital, Den Bosch0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
70

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children aged 8-18 years are included if they meet the criteria for functional dyspepsia, IBS, functional abdominal pain (FAP) or abdominal migraine, based on the Rome III Criteria for Functional Bowel Disorders Associated with Abdominal Pain or Discomfort in Children and have small intestinal bacterial overgrowth, diagnosed on hydrogen breath test as a fasting breath hydrogen concentration > 20 ppm or an increase of H2 levels of > 12 p.p.m. over the baseline value after ingestion of glucose.

排除标准

  • 1. Children with abdominal pain as result of inflammatory, anatomic, metabolic or neoplastic disease;
  • 2. Children who were prescribed antibiotics or probiotics in the last month;

研究者

发起方
Jeroen Bosch hospital, Den Bosch

相似试验